Malaria in pregnancy in rural Gabon: a cross-sectional survey on the impact of seasonality in high-risk groups
© Jäckle et al.; licensee BioMed Central Ltd. 2013
Received: 12 August 2013
Accepted: 28 October 2013
Published: 13 November 2013
Malaria remains one of the most important infectious diseases in pregnancy in sub-Saharan Africa. Whereas seasonal malaria chemoprevention is advocated as public health intervention for children in certain areas of highly seasonal malaria transmission, the impact of seasonality on malaria in pregnancy has not yet been investigated for stable, hyper-endemic transmission settings of Equatorial Africa. The aim of this study was to investigate the influence of seasonality on the prevalence of malaria in pregnancy in Gabon.
The study was conducted at a rural district hospital in Gabon between January 2008 and December 2011. At first antenatal care visits demographic data, parity, age, and gestational age of pregnant women were documented and thick blood smears were performed for the diagnosis of malaria. Seasonality and established risk factors were evaluated in univariate and multivariate analysis for their association with Plasmodium falciparum infection.
1,661 pregnant women were enrolled in this study. Participants presenting during high transmission seasons were at significantly higher risk for P. falciparum infection compared to low transmission seasons (adjusted odds ratio [AOR] 1.91, 95% confidence interval [CI] 1.39-2.63, p < 0.001). Established risk factors including parity (AOR 0.45, CI 0.30-0.69, p < 0.001 for multipara versus paucipara) and age (AOR, CI and p-value for women aged 13–17, 18–22, 23–27 and ≥28 years, respectively: AOR 0.59, CI 0.40-0.88; AOR 0.57, CI 0.34-0.97; AOR 0.51, CI 0.29-0.91) were significant risk factors for P. falciparum infection. High-risk groups including nulli- and primipara and younger women aged 13–17 years showed a disproportionately increased risk for malaria in high transmission seasons from 17% to 64% prevalence in low and high transmission periods, respectively.
Seasonal variations lead to important differences in the risk for P. falciparum infection in pregnancy in the setting of central African regions with stable and hyper-endemic malaria transmission. The seasonal increase in malaria in pregnancy is most pronounced in high-risk groups constituted by young and pauciparous women. The evaluation of tailored seasonal prevention strategies for these high-risk populations may, therefore, be warranted.
KeywordsMalaria Pregnancy Risk factors Parity Age Gestational age Season Seasonality IPTp
An estimated 25 million women are at risk to become infected by Plasmodium falciparum during pregnancy in sub-Saharan Africa each year [1, 2]. Adverse birth outcomes due to malaria in pregnancy include an increased prevalence of maternal anaemia, low birth weight, premature birth and neonatal mortality [3, 4]. The World Health Organization (WHO) recommends a three-pronged strategy against malaria in pregnancy based on the use of insecticide-treated bed nets (ITNs), effective case management and the administration of intermittent preventive treatment against malaria in pregnancy (IPTp) with sulphadoxine-pyrimethamine (SP) [5, 6].
Malaria epidemiology in Gabon is characterized by stable, hyper-endemic transmission of more than 90% P. falciparum. In previous surveys little variation in malaria transmission throughout the year has been observed . The climate is characterized by two rainy and two dry seasons . Malaria in pregnancy is among the most important health problems for pregnant women and the national malaria control programme recommends the use of ITNs and SP-IPTp. The implementation of IPTp has led to a considerable decline in P. falciparum infection in pregnant women in Gabon . Established risk factors for adverse birth outcome and malaria in pregnancy including pauciparity and young age have been equally established in Gabon , however there is no information about the influence of seasonal variations in malaria transmission on the prevalence of malaria in pregnancy in Gabon.
Based on the observation of high seasonality of malaria transmission in certain African regions including large parts of the Sahel, the concept of seasonal malaria chemoprevention has been developed for children . This concept advocates administration of amodiaquine (AQ) and SP only during peak transmission seasons to minimize drug exposure and at the same time maximizing the protective effect of AQ and SP against malaria. To date it is unclear whether similar interventions would be feasible for the prevention of malaria in pregnancy. To better understand the impact of seasonality on the risk for malaria in pregnancy in a central African region with little seasonal variation in malaria transmission we conducted this cross sectional study.
Study region and study population
This study was conducted in the town of Fougamou (approximately 8,000 inhabitants) in the rural province of la Ngounié in Gabon. The region is located in a hilly, rainforest covered area with predominance of subsistence farming as professional activity. The climate is equatorial and meteorological data indicate two dry seasons (December - January and June - September) and two rainy seasons (September - November and February – May, [8, 12]. The average annual temperature is 26°C and humidity is above 80% . Malaria transmission is characterized as hyperendemic and P. falciparum shows high resistance against chloroquine and increasing resistance against SP [13, 14]. The Ngounié Medical Research Centre, a satellite site of the Centre de Recherches Médicales de Lambaréné , is providing laboratory and parasitological services for the local governmental hospital, which is the only health care institution serving the local population.
Pregnant woman presenting for their first antenatal care visit at the hospital were enrolled in this study. All pregnant women received a mother-child health booklet at presentation and bodyweight, blood pressure, uterine height and gestational age according to the first day of the last menstruation were recorded. All women were offered thick blood smear evaluation performed according to the Lambaréné method  for the diagnosis of malaria which were read and prove-read by experienced study professionals guaranteeing high quality data. The following data were captured in a central register: age, parity, date of visit and results of malaria diagnostics. Data were extracted from this register and entered in an electronic database. All women with malarial infection received treatment following current national recommendations.
All thick blood smears were defined as positive if any asexual forms of P. falciparum were observed. Pregnant women were categorized as nulli-, primi- and multipara depending on the number of self-reported previous pregnancies. Women were categorized in the following four age groups based on legal age and 5 year intervals: 13–17 years, 18–22 years, 23–27 years, and 28 or more years of age. With the aim to determine low- and high-risk seasons for malaria transmission throughout the year, the proportion of positive blood smears was calculated for each month during the study period. The month March (malaria prevalence of 13.9%) was chosen as cut-off point determining the risk-periods based on concordant annual trends during the study period: Low-risk periods were in April and between June and September (high-risk periods were May and October - March). Gestational age was calculated according to the reported first day of last menstruation. Ethical approval for this retrospective analysis of clinical data that were obtained from routine clinical records was provided by the Comité d’Ethique Régional et Independent de Lambaréné.
Data were imported for further analysis into a commercial statistical software package (IBM SPSS Statistics, version 19.0). Descriptive analyses were performed and a binary logistic regression model was used to compute the adjusted odds ratios (AOR) of independent risk factors for malaria in pregnancy. To minimize exclusion of data due to missing values binary logistic regression model was computed for two scenarios: including 1) participants with all data (parity-, age-, season- and trimester-group) available for analysis and 2) participants with data for parity, age and season. Since this sensitivity analysis demonstrated only minimal differences, the model with fewest exclusion is shown. Statistical significance was defined by a likelihood ratio with a p-value below 0.05. 95% confidence intervals (CI) were calculated by the exact binominal method.
Characteristics of study population
Demographic characteristics of study population and prevalence of malaria in pregnancy in 2008–2011
Age* (in years)
Age groups stratified
(13–17, 18–22, 23–27, 28+; n)
17%, 32%, 22%, 29%; 1634
29%, 22%, 49%; 1545
(NP, PP, MP; n)**
Parity* in age group 1
0 (0–1; 264)
Parity* in age group 2
1 (0–2; 491)
Parity* in age group 3
2 (1–4; 341)
Parity* in age group 4
4 (2–7; 428)
Nullipara* (Age in years)
18 (15–34; 448)
Primipara* (Age in years)
20 (18–26; 333)
Multipara* (Age in years)
28 (22–38; 743)
24%, 69%, 8%; 769
(1st, 2nd, 3rd; n)
Malaria pos. n (%)
95 % CI
Risk factor analysis for malaria in pregnancy
Results of the binary logistic regression: malaria prevalence in different risk groups (2008–2011)
Malaria pos. n(%)
OR* (95% CI)
AOR** (95% CI)
Age in years
Malaria prevalence decreased significantly from age group 1 to age group 4 and pregnant women attending antenatal care visits in their first trimester had the highest risk for P. falciparum infection with a prevalence of 23% (n = 40). In binary logistic regression for gestational age defined as an ordinal variable, the model showed a significant association of gestational age with a decrease in malaria positivity from the first to the third trimester (AOR 0.66, CI 0.45-0.97, p = 0.035, not shown in Table 2).
Impact of seasonality on the risk for malaria in pregnancy
Impact of seasonality on the risk for malaria in pregnancy in high-risk groups
The solid curve and the dashed curve (drawn in black) in Figure 1 depicts the distribution of malaria prevalence in pregnancy from 2008–2011 for high-risk pregnant women including young (13–17 years of age), nulli- and primiparous women compared to low-risk women (age above 17 years, at least two pregnancies). In every month the high-risk group (solid curve) had a markedly higher prevalence of P. falciparum infection than the low-risk group (dashed curve). Highest prevalence was observed in January (64%) and lowest in September (17%), indicating a higher degree of variation in this high-risk group compared to the general study population.
This study demonstrates that marked seasonal variations in the prevalence of P. falciparum infection in pregnancy occurs in a rural Central African community in Gabon. The finding of an AOR of 1.91 seems surprisingly high on the background of perennial, stable and hyper-endemic malarial transmission in Gabon . Besides seasonality several other risk factors including parity and maternal and gestational age were independently associated with the risk for P. falciparum infection. Whereas these data confirm previous findings [8, 10, 17–22], the sub-analysis of a high-risk group of young and pauciparous women showed even more pronounced seasonal variations in malaria prevalence with maximum monthly prevalence rates varying from 64% in January to 17% in September. This potentiating effect of seasonality on established risk factors in the setting of perennial stable malaria transmission has not yet been well described. The epidemiological description of these sub-groups of pregnant women with disproportionally high-risk for P. falciparum infection may emphasize the need of effective prevention programs in this high-risk group for the prevention of malaria in pregnancy.
To date SP-IPTp is - besides the use of ITNs and case management - the recommended strategy of the WHO in most of sub-Saharan African countries to combat malaria in pregnancy . Current recommendations advocate for the provision of at least three therapeutic doses of SP to all pregnant women after the first trimester . The markedly increased risk for malaria in pregnancy in certain risk groups such as very young women, women in their first pregnancy and women having pregnancies during high transmission seasons is not reflected by the uniform recommendation for SP-IPTp in sub-Saharan Africa [5, 6]. However, these data may be seen as supportive evidence justifying further clinical evaluation of tailored prevention strategies based on seasonal and demographic risk stratification.
Whereas our study aptly analyses risk factors and their association with malaria in pregnancy, several limitations of the study design need to be acknowledged. Firstly, this study is designed as a cross-sectional survey collecting data only at the first antenatal care visit. Therefore no robust estimate on the incidence of P. falciparum infections in the course of pregnancy can be drawn from this study. Similarly, data have been obtained from a hospital registry and potential problems in data accuracy can therefore not be excluded. Finally, the influence of concomitant intake of anti-malarial drugs cannot be ruled out. However, since all women presented for their first antenatal care visit, no major confounding by the intake of SP-IPTp is anticipated.
Even in Central African regions with stable, perennial and hyper-endemic malaria transmission, seasonality leads to important variations in the prevalence of malaria in pregnancy. These variations are even more pronounced in high-risk groups of young and pauciparous women. These findings evoke reflexions on the potential usefulness of more individualized prevention strategies based on a risk-benefit analysis, for low- and high-risk groups among pregnant women in sub-Saharan Africa.
We thank Sarah Jäckle for statistical assistance.
We acknowledge support by Deutsche Forschungsgemeinschft and Open Access Publishing fund of University Tuebingen.
- Desai M, ter Kuile FO, Nosten F, McGready R, Asamoa K, Brabin B, Newman RD: Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis. 2007, 7: 93-104. 10.1016/S1473-3099(07)70021-X.View ArticlePubMedGoogle Scholar
- Rogerson SJ, Mwapasa V, Meshnick SR: Malaria in pregnancy: linking immunity and pathogenesis to prevention. Am J Trop Med Hyg. 2007, 77: 14-22.PubMedGoogle Scholar
- Steketee RW, Wirima JJ, Hightower AW, Slutsker L, Heymann DL, Breman JG: The effect of malaria and malaria prevention in pregnancy on offspring birthweight, prematurity, and intrauterine growth retardation in rural Malawi. Am J Trop Med Hyg. 1996, 55: 33-41.PubMedGoogle Scholar
- Uneke CJ: Impact of placental Plasmodium falciparum malaria on pregnancy and perinatal outcome in sub-Saharan Africa: II: effects of placental malaria on perinatal outcome; malaria and HIV. Yale J Biol Med. 2007, 80: 95-103.PubMed CentralPubMedGoogle Scholar
- WHO: Intermittent Preventive Treatment of malaria in pregnancy using Sulfadoxine-Pyrimethamine (IPTp-SP).http://www.who.int/malaria/publications/atoz/who_iptp_sp_policy_recommendation/en/Accessed 28 April 2013 2012,
- WHO: Lives at risk: malaria in pregnancy. http://www.who.int/features/2003/04b/en/Accessed 28 April 2013 2003
- Wildling E, Winkler S, Kremsner PG, Brandts C, Jenne L, Wernsdorfer WH: Malaria epidemiology in the province of Moyen Ogoov, Gabon. Trop Med Parasitol. 1995, 46: 77-82.PubMedGoogle Scholar
- Bouyou-Akotet MK, Ionete-Collard DE, Mabika-Manfoumbi M, Kendjo E, Matsiegui PB, Mavoungou E, Kombila M: Prevalence of Plasmodium falciparum infection in pregnant women in Gabon. Malar J. 2003, 2: 18-10.1186/1475-2875-2-18.PubMed CentralView ArticlePubMedGoogle Scholar
- Ramharter M, Schuster K, Bouyou-Akotet MK, Adegnika AA, Schmits K, Mombo-Ngoma G, Agnandji ST, Nemeth J, Afene SN, Issifou S, Isabelle Ndombi O, Maryvonne K, Kremsner PG: Malaria in pregnancy before and after the implementation of a national IPTp program in Gabon. Am J Trop Med Hyg. 2007, 77: 418-422.PubMedGoogle Scholar
- Kurth F, Belard S, Mombo-Ngoma G, Schuster K, Adegnika AA, Bouyou-Akotet MK, Kremsner PG, Ramharter M: Adolescence as risk factor for adverse pregnancy outcome in Central Africa–a cross-sectional study. PLoS One. 2010, 5: e14367-10.1371/journal.pone.0014367.PubMed CentralView ArticlePubMedGoogle Scholar
- WHO: WHO Policy Recommendation: Seasonal Malaria Chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub - region in Africa. http://www.who.int/malaria/publications/atoz/who_smc_policy_recommendation/en/ Accessed 12 June 2013 2012
- meteo365: Lambarene Klimadaten. http://www.meteo365.de/klima,lambarene,148.htmlAccessed April 2012 2009
- Ramharter M, Wernsdorfer WH, Kremsner PG: In vitro activity of quinolines against Plasmodium falciparum in Gabon. Acta Trop. 2004, 90: 55-60. 10.1016/j.actatropica.2003.11.001.View ArticlePubMedGoogle Scholar
- Alloueche A, Bailey W, Barton S, Bwika J, Chimpeni P, Falade CO, Fehintola FA, Horton J, Jaffar S, Kanyok T, Kremsner PG, Kublin JG, Lang T, Missinou MA, Mkandala C, Oduola AM, Premji Z, Robertson L, Sowunmi A, Ward SA, Winstanley PA: Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial. Lancet. 2004, 363: 1843-1848. 10.1016/S0140-6736(04)16350-2.View ArticlePubMedGoogle Scholar
- Ramharter M, Adegnika AA, Agnandji ST, Matsiegui PB, Grobusch MP, Winkler S, Graninger W, Krishna S, Yazdanbakhsh M, Mordmüller B, Lell B, Missinou MA, Mavoungou E, Issifou S, Kremsner PG: History and perspectives of medical research at the Albert Schweitzer Hospital in Lambarene, Gabon. Wien Klin Wochenschr. 2007, 119: 8-12. 10.1007/s00508-007-0857-5.View ArticlePubMedGoogle Scholar
- Planche T, Krishna S, Kombila M, Engel K, Faucher JF, Ngou-Milama E, Kremsner PG: Comparison of methods for the rapid laboratory assessment of children with malaria. Am J Trop Med. 2001, 65: 599-602.Google Scholar
- Clerk CA, Bruce J, Greenwood B, Chandramohan D: The epidemiology of malaria among pregnant women attending antenatal clinics in an area with intense and highly seasonal malaria transmission in northern Ghana. Trop Med Int Health. 2009, 14: 688-695. 10.1111/j.1365-3156.2009.02280.x.View ArticlePubMedGoogle Scholar
- Rogerson SJ, van den Broek NR, Chaluluka E, Qongwane C, Mhango CG, Molyneux ME: Malaria and anemia in antenatal women in Blantyre, Malawi: a twelve-month survey. Am J Trop Med. 2000, 62: 335-340.Google Scholar
- WHO: Initiative for Vaccine Research (IVR), Parasitic Diseases, Malaria. http://wwww.hoint/vaccine_research/diseases/soa_parasitic/en/index4html Accessed 12 May
- Brabin BJ: An analysis of malaria in pregnancy in Africa. Bull World Health Organ. 1983, 61: 1005-1016.PubMed CentralPubMedGoogle Scholar
- Dicko A, Mantel C, Thera MA, Doumbia S, Diallo M, Diakite M, Sagara I, Doumbo OK: Risk factors for malaria infection and anemia for pregnant women in the Sahel area of Bandiagara, Mali. Acta Trop. 2003, 89: 17-23. 10.1016/j.actatropica.2003.07.001.View ArticlePubMedGoogle Scholar
- Nosten F, ter Kuile F, Maelankirri L, Decludt B, White NJ: Malaria during pregnancy in an area of unstable endemicity. Trans R Soc Trop Med Hyg. 1991, 85: 424-429. 10.1016/0035-9203(91)90205-D.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.